Related Experiment Videos

Combination drug therapy in children with exercise-induced bronchospasm

Annals of Allergy
|November 1, 1984
PubMed

Insights

Inhaled metaproterenol and cromolyn can help block exercise-induced bronchospasm (EIB) in children with asthma, even when theophylline is ineffective. Some children may require a combination of all three medications for complete EIB control.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Exercise-induced bronchospasm (EIB) is a common asthma symptom in children.
  • Theophylline is a standard treatment, but may not fully control EIB in all cases.

Purpose of the Study:

  • To evaluate the effectiveness of inhaled metaproterenol and cromolyn in blocking EIB in children with moderately severe asthma.
  • To determine if combination therapy is beneficial for children with persistent EIB despite theophylline treatment.

Main Methods:

  • Fifty-three children with moderately severe asthma were studied.
  • EIB was assessed by a 20% fall in FEV1 or 30% fall in FEF25-75.
  • Children received therapeutic theophylline and were tested with inhaled metaproterenol and/or cromolyn prior to exercise.

Main Results:

  • All 53 children experienced EIB while on theophylline.
  • Inhaled metaproterenol completely blocked EIB in 47 children.
  • Six children required a combination of theophylline, metaproterenol, and cromolyn for complete EIB blockage.

Conclusions:

  • Inhaled metaproterenol is effective in blocking EIB in most children with asthma on theophylline.
  • A subset of children may benefit from combination therapy including theophylline, metaproterenol, and cromolyn for optimal EIB management.

Related Concept Videos